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BACKGROUND

Cerebral cavernomas are rare vascular anomalies and
their expansile growth has been considered to be mainly
due to recurrent hemorrhages. They are not generally
reported to show aggressive behavior.
CASE DESCRIPTION

A 27-year-old male presented with headache, visual disturbances, and a 17-year history of seizures. He was
known to have a temporal lobe lesion on CT scan, consistent with a diagnosis of cavernous malformation but
with no relevant family history. Serial clinical and radiological follow-up revealed a progressive increase in the
size of the lesion with formation of a growing cyst of 7 cm
in diameter, which produced mass effect, resulting in the
clinical picture of cerebral herniation. The patient underwent emergency surgical resection with symptomatic relief. There was no evidence of significant hemorrhage at
surgery.

erebral cavernous malformation (CCM) is
classically considered to be a vascular
hamartoma that presents clinically with seizures,
hemorrhage, or mass effect [8]. Its natural history
has been increasingly clarified in the past two decades with the help of CT and MR scanning and it is
clear that although a genetic predisposition to their
development is fundamental, their behavior can be
dynamic, with change in size and de novo appearance of lesions [3,9]. The expansion of a CCM is
usually subsequent to hemorrhage or to growth of
the cavernomatous matrix [3]. The progression of a
cystic change has been surmised to be secondary
to intralesional hemorrhage [11]. We report here
the unusual evolution of a small epileptogenic temporal cavernous malformation into a cystic mass
large enough to present with impending herniation
but without evidence of significant hemorrhage.

C

CONCLUSION

Cavernous malformations can show expansile growth
without any evidence of a presaging hemorrhagic event
and, in the manner of a neoplastic lesion, present with
raised intracranial pressure and cerebral herniation.
© 2001 by Elsevier Science Inc.
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Case Report
This 27-year-old male was initially evaluated in 1984
for a 2-year history of convulsions. A computed
tomography (CT) scan of the brain showed a left
temporal lobe lesion, which was thought to be a
cavernous malformation (Figure 1). He was placed
on anticonvulsant medications and the seizures
subsequently remained well controlled. In December 1998, he began to suffer headaches of increasing
intensity and a repeat CT scan of the brain showed
an increase in the size of the associated cyst. Three
© 2001 by Elsevier Science Inc.
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Post-contrast CT scan at initial presentation with seizure
disorder. A part solid and part cystic lesion is evident in the left temporal lobe.

1

months later, the headaches became constant and
severe and were associated with episodes of blurring of vision. The CT scan at this time showed
significant enlargement of the cyst (Figure 2).
At the time of admission (in March 1999), the
patient was drowsy and had florid papilloedema
along with bilateral sixth nerve palsies. There were
no motor or sensory deficits but the deep tendon
reflexes were hyperactive in both lower extremities
with an extensor plantar response. Magnetic reso-

CT scan 8 years later when
patient returned with mass effect. There is considerable enlargement of the cyst with enhancement
of its wall and surrounding edema.
There was no hematoma.

2

nance (MR) imaging revealed a large heterogeneous
lesion in the left temporal lobe, composed of a solid
calcified intramural part and a large cystic component (7.5 ⫻ 6 ⫻ 5 cm) associated with perifocal
edema. Midline shift was evident (Figure 3).
Emergency surgical treatment was undertaken
and a low temporal exposure fashioned. As the cyst
was entered through the inferior temporal gyrus,
there was little evidence of recent hemorrhage and
the fluid within the cyst was a pale yellow-green.
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Coronal MRI section before emergency surgery. The
variegated intensity typical of a cavernoma is noted,
with perifocal edema and brain shift.
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The cyst wall was vascularized. As the solid vascular tumor component was excised, hemosiderin
staining in the left parahippocampal gyrus was evident. Histopathological examination revealed the
closely packed tissue of a cavernous malformation
with large vascular spaces, lined by a single layer of
endothelium in both the solid and cystic parts of
the lesion. The darkly stained patches of fine calcification were also visible inside the tumor. At the
time of discharge a week after surgery, the patient’s
clinical evaluation demonstrated improvement of
his symptoms and the sixth nerve palsy had resolved. At a 6-month follow-up visit, he was functionally normal and had not had a seizure.

Discussion
The incidence of cavernomous malformation is
0.5% of all brain tumors in large prospective series
[3]. Although clinical onset is observed at all ages
with equal incidence in both sexes, 25% of cases are
diagnosed under the age of 18 years; most of these
occur in males, the incidence of overt hemorrhages
is significantly high in females [3,10]. They usually
present with epilepsy, intraparenchymal hemorrhages, progressive neurological deficits, and only
rarely with raised intracranial pressure [11].
Zabramski et al recently suggested that the familial
form of CCM is a dynamic disease, in view of the de
novo formation of vascular malformations [14]. It is
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certainly unusual for a case of CCM to present with
impending cerebral herniation.
Radiologically, two forms of CCM may now be
identified, the typical “solid” form and a rare cystic
form [9]. On CT scan, the former type appears as a
discrete, hyperdense calcified lesion with minimal
surrounding edema and mass effect; whereas the
latter type appears as a ring-shaped cystic growth
with mass effect and perifocal edema [9]. Both
types enhance minimally after injection of contrast
[9]. Calcification is seen in 11% to 40% of the cases
[9]. The typical MR image of a cavernous malformation consists of a reticulated or honeycomb core of
mixed density and the cystic form shows a welldefined capsule [12]. Recently, clinical and MRI features of de novo lesions in familial cases of CCM
have been evaluated in terms of lesions/patientyear, concluding that occurrence of de novo lesions
is independent of age, sex, and total number of
pre-existing lesions [1]. With the ease of diagnosis
provided by CT and MR scanning, a wealth of information has been accumulated in the past two decades about the behavior and natural history of
cavernous malformations [6,8,9,12,13]. As they are
generally considered to be hamartomatous lesions,
of particular interest in recent reports has been
documentation of the dynamic nature of CCMs in
some patients, with the appearance of new lesions
or changes in the MR characteristics and size of
demonstrated cavernomous malformations [3]. Interestingly, Notelet et al have attempted to explain
the evolutionary potential of cerebral cavernomas
by immunostaining of proliferative cell nuclear antigen (PCNA) in the endothelium of the lesions [7].
The de novo formation of CCM is well known in
patients affected by the familial form of the disease
and has been reported at a rate of 0.4 lesions per
patient per year [2]. New lesions have been described after both whole brain radiation and stereotactic irradiation [5]. Detwiler et al described a
patient without any family history of this disease or
a history of treatment with cranial radiation, which
invalidates the assumption that CCMs are congenital lesions [2]. The pathophysiology of lesion expansion has been ascribed to growth of the cavernous matrix when the mass is solid, and organization
and encapsulation of a perilesional hemorrhage
where cyst formation occurs [3,10,11,12]. In the
latter instance, an osmotic effect of the blood breakdown products in the cyst has been assumed to
contribute to its enlargement [4]. Neither of these
mechanisms seems to have operated in our case, as
there was little evidence of a hemorrhagic event on
clinical and radiological examination or at surgery.
Unlike the reactive glial wall of a cyst associated
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with resorbing hematomas, the histological appearances of the tumorous (solid) and cystic parts of
the lesion in our patient were similar, suggesting
that the enormous growth was due to a proliferative
mechanism in the lesion itself.
Cavernous malformations are considered to be
histologically benign hamartomas and usually any
growth of this vascular anomaly has been assumed
to be the result of hemorrhage. However, CCMs are
not always clinically dormant lesions with an indolent progression; they can have an acute presentation requiring an immediate neurosurgical
intervention.

Conclusion
We have documented expansion of a cystic cavernoma in the manner of a vascular neoplastic lesion
with aggressive clinicopathological behavior. This
has implications for management, as in our patient.
Although anticonvulsant therapy successfully controlled the seizures after his initial presentation
with a small lesion, the progression of the mass
ultimately required an emergency craniotomy.
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COMMENTARY

The case reported by Siddiqui and Jooma demonstrates the fact that some cerebral cavernomas
present as tumors and not—as is commonly
believed—as vascular malformations.
This patient had a very large lesion, with no sign
of bleeding except some perilesional deposits of
hemodsiderin, corresponding to an oozing phenomenon. This report confirms our own experience
[1,2], which led us to surmise that cavernomas are
in reality benign vascular tumors with a hemorrhagic risk, rather than vascular malformations. It is
important to be aware of this feature both from a
nosological and a practical point of view. When a
neurosurgeon makes the decision to operate on a
cavernoma, it is mandatory that the entire lesion be
removed to prevent regrowth and hemorrhage.
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